CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Vahdat, Saloomeh ^a   Oermann, Eric K ^a   Collins, Sean P ^a   Yu, Xia ^a   Abedalthagafi, Malak ^a   Debrito, Pedro ^a   Suy, Simeng ^a   Yousefi, Shadi ^a   Gutierrez, Constanza J ^a   Chang, Thomas ^a   Banovac, Filip ^a   Anderson, Eric D ^a   Esposito, Giuseppe ^a   Collins, Brian T ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYBERKNIFE; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIATION DOSE; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR VOLUME; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIOSURGERY; SALVAGE THERAPY; SCINTISCANNING; SURVIVAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOSURGERY; SALVAGE THERAPY; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 77949499111     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-6     Document Type: Article

References (25)

1. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. H Blomgren I Lax I Naslund, et al. Acta Oncol 1995 34 861 870 10.3109/ 02841869509127197 7576756
2. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. M Uematsu A Shioda A Suda, et al. Int J Radiat Oncol Biol Phys 2001 51 666 670 11597807
3. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. R Timmerman L Papiez R McGarry, et al. Chest 2003 124 1946 1955 10.1378/chest.124.5.1946 14605072
4. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. H Onishi T Araki H Shirato Y Nagata M Hiraoka K Gomi T Yamashita Y Niibe K Karasawa K Hayakawa Y Takai T Kimura Y Hirokawa A Takeda A Ouchi M Hareyama M Kokubo R Hara J Itami K Yamada, Cancer 2004 101 1623 1631 10.1002/cncr.20539 15378503
5. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. RC McGarry L Papiez M Williams, et al. Int J Radiat Oncol Biol Phys 2005 63 1010 1015 16115740
6. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. R Timmerman R McGarry C Yiannoutsos, et al. J Clin Oncol 2006 24 4833 4839 10.1200/JCO.2006.07.5937 17050868
7. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. J Nyman KA Johansson U Hulten, Lung Cancer 2006 51 97 103 10.1016/j.lungcan.2005.08.011 16213059
8. Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. I Lax V Panettieri B Wennberg, et al. Acta Oncol 2006 45 978 988 10.1080/02841860600900050 16982567
9. Stereotactic radiotherapy with real-time tumor tracking fro non-small cell lung cancer: Clinical outcome. NC van der Voort van Zyp JB Prevost MS Hoogeman, et al. Radiother Oncol 2009 91 296 300 10.1016/j.radonc.2009.02.011 19297048
10. Stereotactic Body Radiation Therapy for Early-Stage Non-small-cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study. A Fakiris R McGarry C Yiannoutsos, et al. Int J Radiat Oncol Biol Phys 2009
11. Outcomes in a Prospective Phase II Trial of medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy. P Baumann J Nyman M Hoyer, et al. J Clin Oncol 2009 24 4833 4839
12. Recent advances of novel targeted therapy in non-small cell lung cancer. JA Katzel MP Fanucchi Z Li, J Hematol Oncol 2009 2 2 10.1186/1756-8722-2-2 19159467
13. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. T Takeda A Takeda E Kunieda, et al. AJR Am J Roentgenol 2004 182 1123 1128 15100106
14. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. T Aoki Y Nagata Y Negoro, et al. Radiology 2004 230 101 108 10.1148/radiol.2301021226 14645881
15. 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. T Ishimori T Saga Y Nagata, et al. Ann Nucl Med 2004 18 669 74 10.1007/BF02985960 15682847
16. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. DJ Hoopes M Tann JW Fletcher JA Forquer PF Lin SS Lo RD Timmerman RC McGarry, Lung Cancer 2007 56 229 234 10.1016/j.lungcan.2006.12. 009 17353064
17. A pilot study of serial 18f-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. MA Henderson DJ Hoopes JW Fletcher, et al. Int J Radiat Oncol Biol Phys 2009
18. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. BT Collins K Erickson CA Reichner, et al. Radiat Oncol 2007 2 39 10.1186/1748-717X-2-39 17953752
19. Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. BT Collins S Vahdat K Erickson, et al. J Hematol Oncol 2009 17;2 1 10.1186/1756-8722-2-1
20. Clinical accuracy of the respiratory tumor tracking system of cyberknife: assessment by analysis of log files. M Hoogeman JB Prévost J Nuyttens, et al. Int J Radiat Oncol Biol Phys 2009 74 1 297 303 19362249
21. Treatment of malignant tumors of the skull base with multi-session radiosurgery. ND Coppa DMS Raper Y Zhang BT Collins KW Harter GJ Gagnon SP Collins WC Jean, J Hematol Oncol 2009 2 16 10.1186/1756-8722-2-16 19341478
22. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens. NS Goldstein M Ferkowicz L Kestin, et al. Am J Clin Pathol 2003 120 720 724 10.1309/P47FYW5U4CRQ0WFE 14608898
23. Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. X Ao L Zhao MA Davis DM Lubman TS Lawrence FM Kong, J Hematol Oncol 2009 2 6 10.1186/1756-8722-2-6 19187543
24. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. MK Gould WG Kuschner CE Rydzak, et al. Ann Intern Med 2003 139 879 892 14644890
25. A Comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. JW Fletcher SM Kymes M Gould, et al. J Nucl Med 2008 49 179 185 10.2967/jnumed.107.044990 18199626